EUVIMEDEUVIMED entdecken
Crossref

Lovastatin enhances humoral and cellular immune responses to H1N1 influenza vaccine

Zuchen Song, Yantong Zhou, Lina Jiao, Tianyu Zhu, Ruihong Yu, Zheng Wang, Yawei Qiu, Jinfeng Miao, Ting Cai, Shun Zhang, Huina Liu, Haifeng Sun und 3 weitere

Veterinary Microbiology · 2025

DOI: 10.1016/j.vetmic.2024.110331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Microbiology, 2025. Verfasst von Zuchen Song und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Traditional Chinese Veterinary Medicine, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China; MOE …. Hauptthemen laut MEDLINE: Lovastatin, Influenza A Virus, H1N1 Subtype, Influenza Vaccines, Immunity, Humoral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Swine Influenza Virus (SIV) is a major respiratory pathogen in swine, causing acute, febrile, and highly transmissible infections. This virus is widespread globally and poses significant risks to human health and social development. Traditional prevention strategies for SIV rely on the use of inactivated vaccines combined with Alum adjuvants. However, this method is limited by insufficient protection due to the lack of cellular immunity provided by Alum adjuvants. In this study, we investigated the effect of lovastatin, a specific inhibitor of the mevalonate pathway, on the immune response in mice vaccinated with the H1N1 vaccine. We focused on its impact on antibody production, as well as T-cell and B-cell development. Our findings reveal that the combination of lovastatin and H1N1 vaccine (Lov/H1N1) significantly enhances the production of H1N1-specific serum IgG and hemagglutination inhibition (HI) antibodies. Additionally, it promotes T-cell activation in both draining lymph nodes (dLNs) and the spleen. Analysis of cytokines produced after antigenic restimulation of splenic lymphocytes from immunized mice showed that the Lov/H1N1 combination induces both Th1-type (IFNγ, TNFα) and Th2-type (IL4, IL6) responses. Moreover, Lov/H1N1 facilitates the formation of germinal centers (GCs), which are crucial for the generation of memory B cells and long-lived plasma cells. These results indicate that lovastatin is a promising adjuvant candidate, capable of inducing robust cellular and humoral immune responses, thereby overcoming the limitations of Alum adjuvants. Our study provides a foundation for future research on combined vaccine strategies, highlighting Lovastatin's potential to enhance vaccine efficacy through improved immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LovastatinInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesImmunity, HumoralImmunity, CellularAnimalsMiceFemaleAntibodies, ViralOrthomyxoviridae InfectionsMice, Inbred BALB CCytokinesAdjuvants, ImmunologicB-LymphocytesT-LymphocytesImmunoglobulin GSwine

Stichwörter der Autor:innen

H1N1Immune responsesLovastatinVaccine

Substanzen

LovastatinInfluenza VaccinesAntibodies, ViralCytokinesAdjuvants, ImmunologicImmunoglobulin G

Autor:innen und Institutionen

  • Institute of Traditional Chinese Veterinary Medicine, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China; MOE Joint International Research Laboratory of Animal Health and Food Safe…
  • MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China.
  • Guoke Ningbo Life Science and Health Industry Research Institute, Ningbo, Zhejiang 315032, PR China.
  • Key Laboratory of Bacteriology, Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China.
  • Institute of Traditional Chinese Veterinary Medicine, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China; Guoke Ningbo Life Science and Health Industry Research Institute, Ningbo,…

Zitieren

APA

Song, Z., Zhou, Y., Jiao, L., Zhu, T., Yu, R., Wang, Z., Qiu, Y., Miao, J., Cai, T., Zhang, S., Liu, H., Sun, H., Sun, Y., Wang, D., & Liu, Z. (2025). Lovastatin enhances humoral and cellular immune responses to H1N1 influenza vaccine. Veterinary Microbiology. https://doi.org/10.1016/j.vetmic.2024.110331

Vancouver

Song Z, Zhou Y, Jiao L, Zhu T, Yu R, Wang Z, et al. Lovastatin enhances humoral and cellular immune responses to H1N1 influenza vaccine. Veterinary Microbiology. 2025. doi:10.1016/j.vetmic.2024.110331

BibTeX
@article{Song2025,
  author = {Song, Zuchen and Zhou, Yantong and Jiao, Lina and Zhu, Tianyu and Yu, Ruihong and Wang, Zheng and Qiu, Yawei and Miao, Jinfeng and Cai, Ting and Zhang, Shun and Liu, Huina and Sun, Haifeng and Sun, Yuechao and Wang, Deyun and Liu, Zhenguang},
  title = {Lovastatin enhances humoral and cellular immune responses to H1N1 influenza vaccine},
  journal = {Veterinary Microbiology},
  year = {2025},
  doi = {10.1016/j.vetmic.2024.110331}
}
Kostenlos starten →